Marijo Bilusic

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Topics

Prostate Cancer

Radical Prostatectomy

Top Venues

Journal for immunotherapy of cancer

Cancer management and research

Prostate cancer and prostatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Margaret E Gatti-Mays, Nicholas P Tschernia, Julius Strauss, Ravi A Madan, Fatima H Karzai, Marijo Bilusic, Jason Mark Redman, Houssein Abdul Sater, Charalampos S Floudas, Nicole J Toney, Renee N Donahue, Caroline Jochems, Jennifer L Marté, Deneise Francis, Sheri McMahon, Elizabeth Lamping, Lisa M Cordes, Jeffrey Schlom, James L Gulley
A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors. The oncologist (2023)
Marijo Bilusic, Nicole J Toney, Renee N Donahue, Susan Wroblewski, Matthew Zibelman, Pooja Ghatalia, Eric A Ross, Fatima Karzai, Ravi A Madan, William L Dahut, James L Gulley, Jeffrey Schlom, Elizabeth R Plimack, Daniel M Geynisman
A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1). Prostate cancer and prostatic diseases 25 (4) (2022)
Marijo Bilusic, James L Gulley
Neoadjuvant Immunotherapy: An Evolving Paradigm Shift? Journal of the National Cancer Institute 113 (7) (2022)
Peter Joseph DeMaria, Katherine Lee-Wisdom, Renee N Donahue, Ravi A Madan, Fatima Karzai, Angie Schwab, Claudia Palena, Caroline Jochems, Charalampos S Floudas, Julius Strauss, Jennifer L Marté, Jason Mark Redman, Eva Dombi, Brigitte Widemann, Borys Korchin, Tatiana Adams, Cesar Pico-Navarro, Christopher Heery, Jeffrey Schlom, James L Gulley, Marijo Bilusic
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer. Journal for immunotherapy of cancer 9 (9) (2022)
Marijo Bilusic
What are the advantages of neoadjuvant immunotherapy over adjuvant immunotherapy? Expert review of anticancer therapy 22 (6) (2022)
Marijo Bilusic, Sheri McMahon, Ravi A Madan, Fatima Karzai, Yo-Ting Tsai, Renee N Donahue, Claudia Palena, Caroline Jochems, Jennifer L Marté, Charalampos S Floudas, Julius Strauss, Jason Redman, Houssein Abdul Sater, Shahrooz Rabizadeh, Patrick Soon-Shiong, Jeffrey Schlom, James L Gulley
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC). Journal for immunotherapy of cancer 9 (3) (2021)
Ravi A Madan, Fatima Karzai, Renee N Donahue, Munjid Al-Harthy, Marijo Bilusic, Inger I Rosner, Harpreet Singh, Philip M Arlen, Marc R Theoret, Jennifer L Marté, Lisa M Cordes, Anna Couvillon, Amy Hankin, Moniquea Williams, Helen Owens, Sarah E Lochrin, Cindy H Chau, Seth Steinberg, William Douglas Figg, William Dahut, Jeffrey Schlom, James L Gulley
Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer. Journal for immunotherapy of cancer 9 (3) (2021)
Julius Strauss, Margaret E Gatti-Mays, Byoung Chul Cho, Andrew Hill, Sébastien Salas, Edward McClay, Jason M Redman, Houssein Abdul Sater, Renee N Donahue, Caroline Jochems, Elizabeth Lamping, Andrea Burmeister, Jennifer L Marté, Lisa M Cordes, Marijo Bilusic, Fatima Karzai, Laureen S Ojalvo, Genevieve Jehl, P Alexander Rolfe, Christian S Hinrichs, Ravi A Madan, Jeffrey Schlom, James L Gulley
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies. Journal for immunotherapy of cancer 8 (2) (2021)
Marijo Bilusic, Daniel Girardi, Yan Zhou, Kyungsuk Jung, Jianming Pei, Michael Slifker, Qingrong Chen, Daoud Meerzaman, Katherine Alpaugh, Denise Young, Douglas Flieder, Phillip Gray, Elizabeth Plimack
Molecular Profiling of Exceptional Responders to Cancer Therapy. The oncologist 26 (3) (2020)
Fatima Karzai, Stephanie M Walker, Scott Wilkinson, Ravi A Madan, Joanna H Shih, Maria J Merino, Stephanie A Harmon, David J VanderWeele, Lisa M Cordes, Nicole V Carrabba, John R Bright, Nicholas T Terrigino, Guinevere Chun, Marijo Bilusic, Anna Couvillon, Amy Hankin, Monique N Williams, Rosina T Lis, Huihui Ye, Peter L Choyke, James L Gulley, Adam G Sowalsky, Baris Turkbey, Peter A Pinto, William L Dahut
Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
Vincent Chau, Marijo Bilusic
Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date. Cancer management and research 12 (2020)
Ravi A Madan, Fatima H Karzai, Munjid Al Harthy, Daniel P Petrylak, Joseph W Kim, Philip M Arlen, Inger Rosner, Marc R Theoret, Lisa Cordes, Marijo Bilusic, Cody J Peer, Nancy A Dawson, Anna Couvillon, Amy Hankin, Moniquea Williams, Guin Chun, Helen Owens, Jennifer L Marte, Min-Jung Lee, Yusuke Tomita, Akira Yuno, Jane B Trepel, Sunmin Lee, Seth M Steinberg, James L Gulley, William D Figg, William L Dahut
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer. BJU international 127 (4) (2020)